900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	est un(e) (attribut)	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Campylobacter laridis	Campylobacter lari
Campylobacter laridis rRNA	Campylobacter lari rRNA
Campylobacter laridis rRNA assay	Campylobacter lari rRNA assay
Campylobacter nitrofigilis	Arcobacter nitrofigilis (organism)
Canakinumab 150mg powder for injection solution (product)	Canakinumab only product
Cancer care plan (qualifier value)	Cancer care plan
Cancer care plan	Cancer care plan
Cancer care plan	Cancer care plan
Cancer care review (regime/therapy)	Cancer care review (procedure)
Cancer cervix - screening done	Screening for malignant neoplasm of cervix done (situation)
Candida famata (organism)	Debaryomyces hansenii
Candida famata (organism)	Debaryomyces hansenii
Candida humicola	Vanrija humicola (organisme)
Candida krusei var. vanlaeriana	Pichia membranifaciens (organism)
Candida lipolytica	Yarrowia lipolytica (organism)
Candida pseudotropicalis	Kluyveromyces marxianus (organism)
Candidiasis of other specified sites (disorder)	Candidiasis
Candidiasis of other urogenital sites (disorder)	candidose urogénitale
Canine cortical hyperostosis	Disorder of bone (disorder)
Canis familiaris	Canis lupus subspecies familiaris (organism)
Canis rufus	Canis lupus subspecies rufus (organism)
Cannabinoid (product)	Cannabis (substance)
Cannabinoid - non-pharmaceutical	Cannabis (substance)
Cannabis dependence with current use (disorder)	Cannabis dependence
cannabis non pharmaceutique	Cannabis (substance)
feuilles de cannabis non pharmaceutiques	Cannabis leaf (substance)
huile de cannabis non pharmaceutique	Cannabis oil (substance)
résine de cannabis non pharmaceutique	Cannabis resin (substance)
Cannulation - action	action : insertion
Capillary hemangioma - category (morphologic abnormality)	Capillary hemangioma
Capnocytophaga canimorsus (organism)	Capnocytophaga canimorsus
Caprine adenovirus	Goat adenovirus (organism)
Capsaicin 179mg/hour transdermal patch (product)	Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)
Capsule of distal interphalangeal joint of great toe	Structure of capsule of interphalangeal joint of great toe
Captopril allergy	Non-allergic hypersensitivity to captopril (finding)
Carbachol 1% eye drops (product)	Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug)
Carbachol 1.5% eye drops (product)	Carbachol 15 mg/mL eye solution
Carbachol 1.5% solution (product)	Carbachol 15 mg/mL eye solution
Carbachol 250micrograms/mL intraocular injection solution 1mL ampule (product)	Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug)
Carbamazepine 100mg m/r capsule (product)	Carbamazepine only product in oral dose form
Carbamazepine 100mg m/r tablet (product)	Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral capsule (product)	Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral tablet (product)	Carbamazepine only product in oral dose form
Carbamazepine 200mg m/r capsule (product)	Carbamazepine only product in oral dose form
Carbamazepine 200mg prolonged-release oral capsule	Carbamazepine only product in oral dose form
Carbamazepine 300mg m/r capsule (product)	Carbamazepine only product in oral dose form
Carbamazepine 300mg prolonged-release oral capsule (product)	Carbamazepine only product in oral dose form
Carbenoxolone sodium 1% mouthwash granules (product)	Carbenoxolone only product
Carbenoxolone sodium 2% oral gel (product)	Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oral gel (clinical drug)
Carbidopa + levodopa 25mg/100mg m/r tablet (product)	Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 50mg/200mg m/r tablet (product)	Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet (product)	Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet
Carbidopa 25mg (product)	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet (product)	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet (product)	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop (product)	Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup (product)	Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup (product)	Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops (product)	Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet (product)	Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet	Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent (substance)	hydrate de carbone
Carbol fuchsin stain (substance)	Carbol-fuchsin (substance)
Carbon-carbon lyase	Carbon-carbon lyase
Carbon-halide lyase	Carbon-halide lyase
Carbon-nitrogen lyase	Carbon-nitrogen lyase
Carbon-oxygen lyase	Carbon-oxygen lyase
Carbon-sulfur lyase	Carbon-sulfur lyase
Carboxy-lyase	Decarboxylase
Carboxylic ester hydrolase	Carboxylesterase (substance)
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe (product)	Product containing only carmellose and durapatite in parenteral dose form (medicinal product form)
Carboxymethylcellulose sodium 16.58% oral paste	Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug)
Carbuncle of head, except face	Carbuncle of head
Carbuncle of other specified site (disorder)	anthrax de la peau et/ou du tissu sous-cutané
Carcinoid tumor	Malignant carcinoid tumor
Carcinoid tumor, argentaffin (morphologic abnormality)	Carcinoid tumor - argentaffin
Carcinoma in situ - category (morphologic abnormality)	Carcinoma in situ (morphologic abnormality)
Carcinoma in situ neoplastic process	Carcinoma in situ (morphologic abnormality)
Carcinoma in situ tumor	Carcinoma in situ (disorder)
Carcinoma in situ	Carcinoma in situ (morphologic abnormality)
Carcinoma of cervix stage 0	Carcinoma in situ of uterine cervix
Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding (finding)	American Joint Committee on Cancer allowable value
Carcinoma resembling breast carcinoma (morphologic abnormality)	Carcinoma (morphologic abnormality)
Carcinoma	Carcinoma (morphologic abnormality)
Cardiac end diastolic volume	Cardiac end-diastolic volume (observable entity)
Cardiac glycoside adverse reaction	effet indésirable de Digitalis glycoside
Cardiac status not worse than preoperative baseline (finding)	Cardiac status is consistent with or improved from preoperative baseline (finding)
Cardiospasm (disorder)	Achalasia of oesophagus
cirrhose cardiotuberculeuse	Cirrhosis of liver
Care of venous dissection	Procedure on cardiovascular system
Care plan	Care plan (record artifact)
plan de soins	Care plan (record artifact)
Care plan	Care plan (record artifact)
Cares for mentally handicapped dependent	Caregiver of dependent with intellectual disability
Carglumic acid 200mg dispersible tablet (product)	Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Carglutamic acid 200mg dispersible tablet (product)	Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug)
Caring environment	Caring environment (finding)
Carlavirus	Genus Carlavirus
Carmellose sodium 0.5% eye drops (product)	Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug)

Start Previous Page 15 of 132 Next End

Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)